REPORTS FROM COUNTRIES

possible (or necessary) forall patients. Gynuity is committed to conducting ground-breakingresearch helping to develop new clinical care models. Gynuity Health Projects. E-mail, 20 March 2020 +++ Ohio abortionproviders told to

TEL-ABORTION SERVICES EXPAND TO TEN STATES

Gynuity Health Projects writes: As part of our effort toimprove access to abortion care, especially among populations who may facebarriers, we recently launched the Spanish version of our TelAbortion website.Both

REGISTERING MIFEPRISTONE FOR OTHER INDICATIONS

health care providers. More indications could also increasedemand, and… may in turn generate interest by pharmaceutical companies topursue its marketing and distribution… Gynuity Health Projects has worked for almost two

SECOND TRIMESTER MA AS A DAY SERVICE

six clinical studies of second-trimester medical abortion conducted by Gynuity Health Projects over the past 10 years. We include 868 individuals receiving mifepristone–misoprostol abortion between 13 and 22 weeks’ gestation.

GYNUITY HEALTH PROJECTS NEWS

I. Online course for health care providers in Latin America on midwifery and task-sharing Gynuity’s one-day training developed for public sector health providers in Mexico, has been adapted as an

THE CAMPAIGN IN 2018: WHAT THE COORDINATION TEAM DID

Medical Students, March 2018 Inroads Second Global Members Gathering, Zagreb, Croatia, March 2018 Gynuity Annual Mifepristone Meeting, New York, June 2018 Report of the Lancet SRHR Commission, London, June 2018

Statements from International Leaders and Members’ Activities

is a fundamental human rights issue to provide information about and access to contraceptives and abortions services for every single women.” ************************************************** BEVERLY WINIKOFF, GYNUITY HEALTH PROJECTS “We join friends